Enhancement of Chitosan Nanoparticle and Cyclosporine Tolerance for Future Applications | ||||
| Egyptian Journal of Veterinary Sciences | ||||
| Articles in Press, Corrected Proof, Available Online from 05 August 2024 PDF (1.2 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejvs.2024.295864.2153 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Essa D. Alhtheal  1; Sufian Saleh Salman2
| ||||
| 1Nanotechnology and advanced material research Center, University of Technology-Iraq, Baghdad, Iraq. | ||||
| 2Department of Internal and Preventive Medicine, College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq | ||||
| Abstract | ||||
| Applications for cancer treatment widely use reliable cyclosporine compounds combined with the organic polymer chitosan nanoparticles. The surface chemical characteristics of the chitosan/cyclosporine nanoparticles were investigated using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and particle size (PS) measurements. Field-emission scanning microscopy (FESM) was used to obtain morphological images of the composite materials. The homogenous composition and interaction between chitosan and cyclosporine performed well for future studies, supporting this study are its nanoparticle applications. The proposed chitosan nanoparticle manufacturing process is simple, low-cost and environmentally friendly. Moreover, these advantages indicate the possibility of using interesting samples for cancer treatment applications in advanced biomedical and practical fields. | ||||
| Keywords | ||||
| chitosan nanoparticles; biomedical; drug delivery; nanomaterials | ||||
|
Statistics Article View: 130 PDF Download: 92 |
||||
